We need to stop companies from using loopholes to sell unproven cell therapies to desperate patients

A handful of cell- and gene-based therapies have now been approved, and more are sure to follow.

A consortium aims to tackle cardiovascular disease with cell therapies

Can cell and gene therapies paint a picture of perfect future health?

Tracing the supply chain back to raw materials and learning how fundamental research is driving advances in cell culture media.

Raymond Sackler, philanthropist, psychopharmacology pioneer, and former CEO of Purdue Pharma, dies aged 97.

Each new drug is unique and deserves a fresh approach to formulation.

Can enzyme immobilization enhance biocatalysis further?

Why stop at biosimilar when you can be biobetter?

Big Pharma can impact millions of lives, but charity on a smaller scale also makes a difference.